Study guide

17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies

Key Takeaways Explain This Topic AI

The elevated ratio of alveolar ventilation to functional residual capacity (Va:FRC ~5:1 vs ~1.5:1 in adults) and low blood-gas solubility accelerate inhalational induction and emergence with sevoflurane in young children.

Modern micro-cuff endotracheal tubes are preferred across all paediatric age groups; ultrathin polyurethane cuffs seal at pressures <20 cmH2O, eliminating repetitive intubations and preventing subglottic ischaemic stenosis.

Maintenance fluid therapy adheres to the Holliday-Segar 4-2-1 rule using isotonic balanced crystalloids; routine inclusion of 1% to 2.5% dextrose is indicated in neonates and infants <12 months to prevent hypoglycemia while avoiding hyponatremic encephalopathy.

Laryngospasm management progresses systematically from Larson's notch jaw thrust and continuous positive airway pressure (CPAP) with 100% oxygen to IV propofol and suxamethonium (0.5-2.0 mg/kg IV or 4 mg/kg IM with atropine).

Croup presents with a gradual onset, barking cough, and subglottic steeple sign (managed with dexamethasone and nebulized adrenaline), whereas acute epiglottitis is a fulminant supraglottic emergency presenting with a thumb sign, drooling, and tripod posturing, requiring undisturbed transfer to the operating theatre for inhalational induction.

Last updated: October 2026

17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies

Paediatric anaesthesia demands precise comprehension of dynamic anatomical transformations, distinct metabolic and fluid requirements, and unique pharmacological profiles across developmental stages from the neonate to the adolescent.

1. Preoperative Psychological Preparation and Pharmacological Premedication

Minimizing perioperative anxiety in children reduces distress during induction, lowers postoperative analgesic requirements, and mitigates long-term maladaptive behavioural changes (e.g. night terrors, separation anxiety, and regressive behaviours).

Psychological Factors Across Developmental Stages

Infants (<8 months): Minimal separation anxiety; tolerate separation if warm, fed, and comfortable.

Toddlers and Preschoolers (8 months to 5 years): Intense separation anxiety and fear of the unknown. Stranger anxiety peaks between 12 and 24 months.

School-aged Children (6 to 12 years): Fear of bodily injury, pain, loss of control, and death; benefit from honest, developmentally tailored verbal explanations.

Adolescents (>12 years): Fear of loss of autonomy, altered body image, and waking during surgery.

Non-Pharmacological Strategies: Parental presence at induction of anaesthesia (PPIA) can benefit select calm parents and older children, but an anxious parent significantly intensifies child distress. Distraction techniques (tablets, interactive video games, medical play therapy) are highly effective.

Pharmacological Premedication

Premedication Agent Route & Dosage Onset & Duration Clinical Advantages & High-Yield Features

Oral Midazolam 0.5 − 0.75 mg/kg 0.5 - 0.75\text{ mg/kg} 0.5 − 0.75 mg/kg PO (max 15 − 20 mg 15 - 20\text{ mg} 15 − 20 mg ) Onset: 15 − 30 min 15 - 30\text{ min} 15 − 30 min ; Duration: 60 − 90 min 60 - 90\text{ min} 60 − 90 min Reliable anxiolysis, sedation, and anterograde amnesia. In 1 − 2 % 1 - 2\% 1 − 2% of children, it precipitates paradoxical agitation, restlessness, and disinhibition.

Intranasal Dexmedetomidine 1 − 2 μ g/kg 1 - 2\text{ }\mu\text{g/kg} 1 − 2 μ g/kg intranasal (via mucosal atomizer) Onset: 25 − 45 min 25 - 45\text{ min} 25 − 45 min ; Duration: 90 − 120 min 90 - 120\text{ min} 90 − 120 min Selective α 2 \alpha_2 α 2 ​ -adrenoceptor agonist; produces cooperative sedation mimicking natural non-REM sleep without respiratory depression. Dramatically reduces the incidence of sevoflurane-induced emergence delirium.

Topical Local Anaesthesia (EMLA Cream) Topical eutectic mixture of 2.5 % 2.5\% 2.5% lidocaine & 2.5 % 2.5\% 2.5% prilocaine Requires ≥ 60 min \ge 60\text{ min} ≥ 60 min under occlusive dressing Anesthetizes skin to depth of 5 mm 5\text{ mm} 5 mm for venous cannulation. Prilocaine metabolite ( o o o -toluidine) oxidizes hemoglobin to methemoglobin; use with caution in neonates.

Topical Amethocaine (Ametop 4% Gel) Topical tetracaine gel Requires 30 − 45 min 30 - 45\text{ min} 30 − 45 min under occlusive dressing Ester local anaesthetic; faster onset than EMLA and induces local venodilation, facilitating vein visualization and puncture.

2. Inhalational vs Intravenous Induction Mechanics and Physiology

Induction of anaesthesia in children may be achieved via inhalational or intravenous routes, each governed by specific physiological principles.

Inhalational Induction with Sevoflurane

Sevoflurane is the preferred volatile induction agent due to its pleasant, non-pungent sweet odor, absence of airway irritation, and low blood-gas partition coefficient ( 0.69 0.69 0.69 ).

Mechanisms of Accelerated Alveolar Wash-in ( F A / F I F_A/F_I F A ​ / F I ​ Rise):

High Ratio of Alveolar Ventilation to FRC ( V A : F R C V_A:FRC V A ​ : FRC ): In neonates and infants, the V A : F R C V_A:FRC V A ​ : FRC ratio is approximately 5 : 1 5:1 5 : 1 (alveolar ventilation ≈ 100 − 150 mL/kg/min \approx 100 - 150\text{ mL/kg/min} ≈ 100 − 150 mL/kg/min ; FRC ≈ 25 − 30 mL/kg \text{FRC} \approx 25 - 30\text{ mL/kg} FRC ≈ 25 − 30 mL/kg ), compared to 1.5 : 1 1.5:1 1.5 : 1 in adults. The alveolar compartment turns over more than three times faster, dramatically accelerating alveolar wash-in of volatile anaesthetic.

Elevated Cardiac Output and Preferential Distribution: Paediatric cardiac index is high ( 180 − 200 mL/kg/min 180 - 200\text{ mL/kg/min} 180 − 200 mL/kg/min in neonates), and a larger proportion of this cardiac output is delivered to the vessel-rich organ group (brain, heart, splanchnic bed, kidneys) than in adults. This ensures rapid cerebral delivery.

Reduced Tissue and Blood Solubility: Lower blood-gas and tissue-gas solubility in young children accelerates blood and brain saturation.

Complications of Inhalational Induction:

Stage II Excitement: Excitatory phase manifested by breath-holding, pupil dilation, conjugate/dysconjugate gaze, involuntary motor movements, and heightened vulnerability to coughing and severe laryngospasm upon tactile stimulation.

Dose-Dependent Myocardial Depression: Paediatric myocardium has fewer organized contractile myofibrils ( 30 % 30\% 30% compared to 60 % 60\% 60% in adults) and immature sarcoplasmic reticulum reliant on extracellular calcium flux. Sevoflurane depresses myocardial contractility and induces profound vasodilation; in hypovolemic infants, rapid 8 % 8\% 8% sevoflurane induction can cause catastrophic bradycardia and cardiovascular collapse.

Intravenous Induction

Propofol Pharmacokinetics: Paediatric induction requires larger doses: 2.5 − 3.5 mg/kg 2.5 - 3.5\text{ mg/kg} 2.5 − 3.5 mg/kg IV in children (younger children often need the upper end of this range). Neonates are the exception: immature clearance and a tendency to prolonged hypotension call for smaller, titrated doses. Children have an expanded extracellular fluid volume and larger central volume of distribution ( V d V_d V d ​ ), alongside elevated hepatic clearance rates relative to body weight.

Vagal Tone Dominance and Bradycardia: The parasympathetic nervous system is fully mature at birth, whereas the sympathetic nervous system is anatomically and functionally immature. Because the infant myocardium is non-compliant, stroke volume is relatively fixed; cardiac output is strictly rate-dependent ( C O = H R × S V CO = HR \times SV CO = H R × S V ). Airway instrumentation, laryngoscopy, or suctioning stimulates intense vagal reflexes, precipitating profound bradycardia, severe hypotension, and asystolic arrest.

Anticholinergic Co-Administration: Intravenous atropine ( 20 μ g/kg 20\text{ }\mu\text{g/kg} 20 μ g/kg , minimum dose 100 μ g 100\text{ }\mu\text{g} 100 μ g to prevent central paradoxical bradycardia) or glycopyrrolate ( 10 μ g/kg 10\text{ }\mu\text{g/kg} 10 μ g/kg ) is strongly recommended during IV induction in neonates and young infants, particularly when co-administering succinylcholine or remifentanil.

3. Paediatric Airway Equipment, Sizing Formulas, and Micro-Cuff Mechanics

Paediatric airway anatomy possesses critical morphological distinctions from the adult that dictate airway equipment selection and intubation technique. [ Adult Larynx (C4-C6) ] [ Infant Larynx (C3-C4) ]

  • Broad, flexible epiglottis - Long, stiff, omega-shaped epiglottis
  • Vocal cords horizontal - Vocal cords slanted anteroinferiorly
  • Narrowest point: Glottic aperture - Narrowest point: Cricoid ring / subglottis
  • Axis alignment: Elevate head (sniffing) - Axis alignment: Shoulder roll (large occiput)
  • Anatomical Distinctives & Laryngoscope Blade Selection

High Larynx: The infant larynx is positioned more cephalad at C3-C4 (descending to C4-C5 by age 6 and C5-C6 in adults). The vocal cords angle anteroinferiorly.

Large Occiput: Causes severe neck flexion when supine. A shoulder roll (folded towel under the scapulae) is required to establish the neutral "sniffing" position; head rings or occipital elevation must be avoided.

Epiglottic Morphology: The paediatric epiglottis is long, narrow, rigid, and omega-shaped ( Ω \Omega Ω ), projecting retroverted at 45 ∘ 45^\circ 4 5 ∘ over the glottis.

Blade Selection:

Straight Miller Blade (Size 0 for neonates, Size 1 for infants): Preferred in infants under 1-2 years. The straight blade is passed posterior to the epiglottis to directly elevate the stiff, floppy epiglottis, providing an unobstructed view of the anterior vocal cords.

Curved Macintosh Blade (Size 2): Introduced in older children ( > 2 − 3 years >2 - 3\text{ years} > 2 − 3 years ) where the blade tip is seated in the vallecula to indirectly elevate the epiglottis.

Equipment Sizing Formulas

Uncuffed ETT Internal Diameter (mm) = Age (years) 4 + 4 \text{Uncuffed ETT Internal Diameter (mm)} = \frac{\text{Age (years)}}{4} + 4 Uncuffed ETT Internal Diameter (mm) = 4 Age (years) ​ + 4

Cuffed ETT Internal Diameter (mm) = Age (years) 4 + 3.5 \text{Cuffed ETT Internal Diameter (mm)} = \frac{\text{Age (years)}}{4} + 3.5 Cuffed ETT Internal Diameter (mm) = 4 Age (years) ​ + 3.5

Oral ETT Depth of Insertion (cm at incisors) = Age (years) 2 + 12 \text{Oral ETT Depth of Insertion (cm at incisors)} = \frac{\text{Age (years)}}{2} + 12 Oral ETT Depth of Insertion (cm at incisors) = 2 Age (years) ​ + 12

Alternatively: Depth of Insertion (cm) = 3 × ETT Internal Diameter (mm) \text{Alternatively: Depth of Insertion (cm)} = 3 \times \text{ETT Internal Diameter (mm)} Alternatively: Depth of Insertion (cm) = 3 × ETT Internal Diameter (mm)

Neonatal ETT Sizing: Preterm < 1000 g <1000\text{ g} < 1000 g : 2.5 mm 2.5\text{ mm} 2.5 mm uncuffed; Preterm 1000 − 2500 g 1000 - 2500\text{ g} 1000 − 2500 g : 3.0 mm 3.0\text{ mm} 3.0 mm ; Term neonate ( > 2500 g >2500\text{ g} > 2500 g ): 3.0 − 3.5 mm 3.0 - 3.5\text{ mm} 3.0 − 3.5 mm . Depth at lip: Weight (kg) + 6 cm \text{Weight (kg)} + 6\text{ cm} Weight (kg) + 6 cm .

Modern Micro-Cuff Paediatric Endotracheal Tubes

Historical Dogma: Classical pediatric teaching asserted that the circular, rigid cricoid cartilage formed a natural subglottic anatomical seal, mandating uncuffed tubes in children under 8 years to avoid subglottic stenosis.

Contemporary Evidence: High-resolution MRI, CT, and dynamic videobronchoscopy demonstrate that the paediatric cricoid lumen is elliptical (narrower transversely than anteroposteriorly), and the functional narrowest point of the upper airway is dynamic at the glottis. Uncuffed tubes produce unpredictable air leaks, requiring tube exchange in 20 − 30 % 20 - 30\% 20 − 30% of cases, increasing mechanical airway trauma, operating room gas pollution, and aspiration risk.

Micro-Cuff Tube Design: Modern cuffed tubes incorporate an ultrathin ( 10 μ m 10\text{ }\mu\text{m} 10 μ m ) polyurethane cuff located distally on the shaft. This allows effective low-pressure sealing ( < 20 cmH 2 O <20\text{ cmH}_2\text{O} < 20 cmH 2 ​ O ) without causing capillary ischaemic necrosis of the tracheal mucosa (capillary perfusion pressure is ∼ 25 − 30 cmH 2 O \sim 25 - 30\text{ cmH}_2\text{O} ∼ 25 − 30 cmH 2 ​ O ). Micro-cuff tubes safely seal the airway, drastically reduce re-intubation rates, protect against pulmonary aspiration, and allow accurate low-flow capnography and tidal volume delivery.

4. Fluid Management and Metabolic Considerations

Paediatric fluid therapy requires precise calculation because children have higher metabolic rates, greater total body water percentages ( 75 − 80 % 75 - 80\% 75 − 80% in neonates vs 60 % 60\% 60% in adults), and limited renal concentrating capacities.

The Holliday-Segar 4-2-1 Maintenance Rule

First 10 kg of body weight: 4 mL/kg/h \text{First 10 kg of body weight: } 4\text{ mL/kg/h} First 10 kg of body weight: 4 mL/kg/h

Second 10 kg (10 to 20 kg): + 2 mL/kg/h ( i.e. 40 mL/h for first 10 kg + 2 mL/kg/h for each kg above 10 ) \text{Second 10 kg (10 to 20 kg): } + 2\text{ mL/kg/h } (\text{i.e. } 40\text{ mL/h for first 10 kg} + 2\text{ mL/kg/h for each kg above 10}) Second 10 kg (10 to 20 kg): + 2 mL/kg/h ( i.e. 40 mL/h for first 10 kg + 2 mL/kg/h for each kg above 10 )

Weight above 20 kg: + 1 mL/kg/h ( i.e. 60 mL/h for first 20 kg + 1 mL/kg/h for each kg above 20 ) \text{Weight above 20 kg: } + 1\text{ mL/kg/h } (\text{i.e. } 60\text{ mL/h for first 20 kg} + 1\text{ mL/kg/h for each kg above 20}) Weight above 20 kg: + 1 mL/kg/h ( i.e. 60 mL/h for first 20 kg + 1 mL/kg/h for each kg above 20 )

Worked Example: A 26 kg 26\text{ kg} 26 kg child requires:

( 10 × 4 ) + ( 10 × 2 ) + ( 6 × 1 ) = 40 + 20 + 6 = 66 mL/h (10 \times 4) + (10 \times 2) + (6 \times 1) = 40 + 20 + 6 = 66\text{ mL/h} ( 10 × 4 ) + ( 10 × 2 ) + ( 6 × 1 ) = 40 + 20 + 6 = 66 mL/h .

The Mandate for Isotonic Balanced Crystalloids

Danger of Hypotonic Solutions: Historical practice utilized hypotonic solutions (e.g., 0.18 % 0.18\% 0.18% or 0.45 % 0.45\% 0.45% sodium chloride with 5 % 5\% 5% dextrose). Perioperative distress, pain, nausea, and surgical stress stimulate non-osmotic secretion of antidiuretic hormone (ADH / arginine vasopressin). High ADH levels impair free-water excretion by the kidneys. Infusing hypotonic fluids in the presence of elevated ADH leads to rapid water retention, acute severe hyponatremic encephalopathy , cerebral oedema, brain herniation, and death in previously healthy children.

Modern Guidelines: European and international consensus mandates the exclusive use of isotonic balanced crystalloids (e.g., Plasmalyte, Hartmann's solution, Ringer's lactate) for routine perioperative maintenance and volume replacement.

Dextrose Requirements

Neonates and infants under 12 months (or children < 10 kg <10\text{ kg} < 10 kg ) possess low hepatic glycogen stores, higher metabolic consumption, and immature gluconeogenic enzyme pathways. In this cohort, baseline maintenance fluids should contain 1.0 % − 2.5 % 1.0\% - 2.5\% 1.0% − 2.5% dextrose in balanced isotonic crystalloid to prevent hypoglycemia ( < 2.6 mmol/L <2.6\text{ mmol/L} < 2.6 mmol/L or < 45 mg/dL <45\text{ mg/dL} < 45 mg/dL ).

Routine infusion of 5 % 5\% 5% dextrose must be avoided, as it reliably triggers hyperosmolar hyperglycemia, osmotic diuresis, and exacerbates cerebral injury in ischaemic events.

5. Common Paediatric Airway Emergencies

Paediatric airway emergencies demand structured algorithmic intervention to avert catastrophic hypoxemia and cardiac arrest.

Laryngospasm

Pathophysiology: Involuntary, sustained reflex closure of true and false vocal cords mediated by superior laryngeal nerve sensory afferents and recurrent laryngeal nerve motor efferents.

Risk Factors: Peak incidence in infants under 1 year; active or recent upper respiratory tract infection (URTI within 2 to 4 weeks, conferring bronchial hyperreactivity for up to 6 weeks); exposure to environmental tobacco smoke; light plane of anaesthesia during airway manipulation; blood or secretions touching the glottic aperture.

Systematic Treatment Ladder:

Stop surgical stimulation; clear blood and secretions with gentle suction.

Administer 100 % O 2 100\%\text{ O}_2 100% O 2 ​ via tight-fitting mask; apply continuous positive airway pressure ( CPAP at 10 − 15 cmH 2 O 10 - 15\text{ cmH}_2\text{O} 10 − 15 cmH 2 ​ O ) to pneumatically separate the vocal folds.

Larson's Maneuver (Laryngospasm Notch Pressure): Apply firm, bilateral, sustained anterior-cephalad force to the laryngospasm notch (behind the condyle and ramus of the mandible, anterior to the mastoid process). This forcefully displaces the tongue anteriorly while intense periosteal stimulation reflexively terminates adductor spasm.

Deepening Anaesthesia: If spasm persists, administer intravenous propofol ( 0.5 − 1.0 mg/kg 0.5 - 1.0\text{ mg/kg} 0.5 − 1.0 mg/kg ). Deepening anaesthesia breaks the reflex arc.

Neuromuscular Blockade: Administer intravenous succinylcholine ( 0.5 − 1.0 mg/kg 0.5 - 1.0\text{ mg/kg} 0.5 − 1.0 mg/kg IV for rapid partial cord relaxation, or 1.0 − 2.0 mg/kg 1.0 - 2.0\text{ mg/kg} 1.0 − 2.0 mg/kg IV for full paralysis). If IV access is lost, administer intramuscular succinylcholine ( 4.0 mg/kg 4.0\text{ mg/kg} 4.0 mg/kg IM) co-administered with atropine ( 20 μ g/kg 20\text{ }\mu\text{g/kg} 20 μ g/kg IM) to prevent succinylcholine-induced severe bradycardia.

Croup vs Acute Epiglottitis

Feature Croup (Laryngotracheobronchitis) Acute Epiglottitis

Etiology Viral (Parainfluenza virus types 1-3, RSV, rhinovirus) Bacterial ( Haemophilus influenzae type b, Streptococcus , Staphylococcus )

Age Group 6 months to 3 years 2 to 7 years (and adults)

Onset & Prodrome Gradual (1-3 days); coryza, low-grade fever, hoarseness Fulminant (hours); high fever ( > 39 ∘ C >39^\circ\text{C} > 3 9 ∘ C ), toxic, rapidly progressive

Clinical Hallmarks Characteristic "barking" seal-like cough; hoarseness; stridor Muffled "hot potato" voice, no cough; drooling , severe dysphagia/odynophagia

Posture Restless; lying flat or sitting Tripod position (sitting, leaning forward, chin thrust, neck extended)

Anatomical Site Subglottic oedema below vocal cords Supraglottic infection of epiglottis and aryepiglottic folds

Radiographic Sign AP neck: "Steeple sign" (symmetric subglottic mucosal narrowing) Lateral neck: "Thumb sign" (swollen, rounded, cherry-red epiglottis)

Management Oral/IV dexamethasone ( 0.15 − 0.6 mg/kg 0.15 - 0.6\text{ mg/kg} 0.15 − 0.6 mg/kg ); nebulized racemic or L-adrenaline ( 0.5 mL/kg 0.5\text{ mL/kg} 0.5 mL/kg 1:1000, max 5 mL 5\text{ mL} 5 mL ) DO NOT DISTURB THE CHILD. Avoid IV cannulation or tongue depressors in ER. Transfer directly to OR with ENT surgeon present. Inhalational induction in sitting position maintaining spontaneous breathing; intubate with ETT 1-2 sizes smaller.

Post-Tonsillectomy Haemorrhage

Clinical Timing: Primary haemorrhage occurs within 24 hours (peak 4 to 8 hours postoperatively, usually surgical slipped vessel); secondary haemorrhage occurs at 5 to 10 days (sloughing of fibrin slough/eschar or local infection).

Resuscitation and Airway Dilemma:

Children swallow large quantities of blood: the stomach is completely full of blood clots, creating an extreme aspiration risk.

Occult hypovolemia: Young children maintain normal arterial pressure despite substantial blood loss ( > 30 % >30\% > 30% volume loss) through intense sympathetic peripheral vasoconstriction. Tachycardia, pallor, delayed capillary refill ( > 3 s >3\text{ s} > 3 s ), and agitation are early signs of profound hypovolemia.

Management Strategy: Aggressive intravascular volume resuscitation with warmed balanced crystalloids (or PRBCs if unstable) BEFORE induction . Two working, high-volume suction units (Yankauer) must be verified. Induction is performed with a slight head-down tilt ( 15 ∘ 15^\circ 1 5 ∘ Trendelenburg) using a rapid sequence induction (RSI) technique with rocuronium or succinylcholine by an experienced anaesthetist. Pass a wide-bore orogastric tube under direct visualization to decompress the stomach before extubation. Extubate only when fully awake and coughing, in the lateral head-down (recovery) position.

Foreign Body Aspiration

Presentation: Most common in toddlers ( 1 − 3 years 1 - 3\text{ years} 1 − 3 years ). Sudden paroxysm of coughing, choking, followed by unilateral wheezing, stridor, or diminished breath sounds. Expiratory chest radiography frequently demonstrates air-trapping (unilateral lung hyperlucency) due to a ball-valve mechanism.

Anaesthetic Management:

Inhalational induction with sevoflurane in 100 % O 2 100\%\text{ O}_2 100% O 2 ​ while maintaining spontaneous respiration throughout.

Critical Rationale: Positive pressure ventilation (PPV) is avoided where possible before bronchoscopy (gentle assisted ventilation may be needed if oxygenation fails); positive pressure can propel the foreign body from a main bronchus into distal segmental branches, convert a partial ball-valve obstruction into complete occlusion, or induce tension pneumothorax.

Spray vocal cords with topical lidocaine; rigid ventilating bronchoscopy is performed by the surgeon to retrieve the foreign body.